Heart Test Company Insiders
| HSCS Stock | USD 3.83 0.41 11.99% |
Heart Test employs about 15 people. The company is managed by 3 executives with a total tenure of roughly 35 years, averaging almost 11.0 years of service per executive, having 5.0 employees per reported executive. Breaking down Heart Test's management performance can provide insight into the firm performance.
Heart |
Heart Test Management Team Effectiveness
The company has return on total asset (ROA) of (0.8169) % which means that it has lost $0.8169 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.6929) %, meaning that it created substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.88 in 2024. Return On Capital Employed is likely to drop to -0.85 in 2024. At this time, Heart Test's Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 217.5 K in 2024, whereas Intangible Assets are likely to drop slightly above 1.3 M in 2024.Common Stock Shares Outstanding is likely to drop to about 334.9 K in 2024. Net Loss is likely to drop to about (6 M) in 2024
Heart Test Workforce Comparison
Heart Test Laboratories is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,389. Heart Test claims roughly 15.0 in number of employees contributing just under 2% to equities under Health Care industry.
Heart Test Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heart Test insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heart Test's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Heart Test insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Andrew Simpson over three months ago Acquisition by Andrew Simpson of tradable shares of Heart Test subject to Rule 16b-3 | ||
Mark Hilz over three months ago Disposition of 3788 shares by Mark Hilz of Heart Test at 12.21 subject to Rule 16b-3 | ||
Bent Bruce over a year ago Acquisition by Bent Bruce of 50000 shares of Heart Test subject to Rule 16b-3 |
Heart Test Notable Stakeholders
A Heart Test stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Heart Test often face trade-offs trying to please all of them. Heart Test's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Heart Test's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andrew Simpson | President CEO | Profile | |
| Mark Hilz | Secretary COO | Profile | |
| Danielle Watson | CFO Treasurer | Profile |
About Heart Test Management Performance
The success or failure of an entity such as Heart Test Laboratories often depends on how effective the management is. Heart Test management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Heart management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Heart management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.83) | (0.88) | |
| Return On Capital Employed | (0.81) | (0.85) | |
| Return On Assets | (0.70) | (0.73) | |
| Return On Equity | (0.90) | (0.95) |
Please note, the imprecision that can be found in Heart Test's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Heart Test Laboratories. Check Heart Test's Beneish M Score to see the likelihood of Heart Test's management manipulating its earnings.
Heart Test Workforce Analysis
Traditionally, organizations such as Heart Test use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Heart Test within its industry.Heart Test Manpower Efficiency
Return on Heart Test Manpower
| Revenue Per Employee | 1.2K | |
| Revenue Per Executive | 6.2K | |
| Net Loss Per Employee | 440.3K | |
| Net Loss Per Executive | 2.2M | |
| Working Capital Per Employee | 373.5K | |
| Working Capital Per Executive | 1.9M |
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.